サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1447964

北米の毒物学研究所市場 - 北米の業界分析、規模、シェア、成長、動向、予測（2023年～2030年）- 薬剤クラス別、製品タイプ別、サンプル別、国別、企業別

North America Toxicology Laboratories Market - North America Toxicology Laboratories Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - (By Drug Class, By Product Type, By Sample, By Geographic Coverage and By Company)
出版日: | 発行: Fairfield Market Research | ページ情報: 英文 100 Pages | 納期: 2～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
北米の毒物学研究所市場 - 北米の業界分析、規模、シェア、成長、動向、予測（2023年～2030年）- 薬剤クラス別、製品タイプ別、サンプル別、国別、企業別
出版日: 2024年03月05日
発行: Fairfield Market Research
ページ情報: 英文 100 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

北米の毒物学研究所の市場規模は、予測期間中のCAGRは10.4％と申し分なく、2023年の2億5,520万米ドルから2030年末には5億1,120万米ドルに急増すると予測されています。

市場拡大を推進する主要動向には、迅速なスクリーニング技術の重要性が高まっていることなどがあります。ガスクロマトグラフィ質量分析（GC-MS）などの技術の進歩により、毒物学研究所では効率的なスクリーニング法に対する需要が急増し、所要時間と感度が向上しています。

本レポートで確認されたもう一つの重要な動向は、毒物学研究所における情報科学とデータソリューションの統合です。機密性の高い検査結果は質量分析データベースに安全に保存され、この業界におけるデータの完全性と機密性の重要性が強調されています。

当レポートでは、北米の毒物学研究所市場について調査し、市場の概要とともに、薬剤クラス別、製品タイプ別、サンプル別、国別、企業別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • 経済概要
  • PESTLE分析

第3章 北米の毒物学研究所市場の見通し、2018年～2030年

  • 北米の毒物学研究所市場の見通し、薬剤クラス別、金額（100万米ドル）、2018年～2030年
  • 北米の毒物学研究所市場の見通し、製品タイプ別、金額（100万米ドル）、2018年～2030年
  • 北米の毒物学研究所市場の見通し、サンプル別、金額（100万米ドル）、2018年～2030年
  • 北米の毒物学研究所市場の見通し、国別、金額（100万米ドル）、2018年～2030年

第4章 競合情勢

  • 企業市場シェア分析、2022年
  • 主要企業別市場集中
  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific
    • Bio-Rad Laboratories, Inc.
    • NEOGEN Corporation
    • Redwood Toxicology Laboratory, Inc.
    • Vala Sciences, Inc.
    • Enzo Life Sciences, Inc.
    • Alere, Inc.
    • Agilent Technologies, Inc.
    • Immunalysis Corporation
    • Danaher Corporation
    • Principle Diagnostics Laboratory
    • Principle Laboratory
    • Principle Diagnostics Laboratory
    • Clinical Reference Laboratory, Inc.
    • Medical Toxicology Laboratory, LLC
    • NMS Labs
    • BATTS Laboratories
    • Total Toxicology
    • Life Brite Labs.
    • Product Safety Labs
    • Lexar Labs

第5章 付録

目次

The North America toxicology laboratories market, unveiling promising forecasts and insightful trends driving the industry's evolution. With an impeccable Compound Annual Growth Rate (CAGR) of 10.4% projected during the forecast period, the market is expected to surge from US$255.2 million in 2023 to an estimated US$511.2 million by the end of 2030.

Rapid Screening Technologies: A Key Driver of Growth

The report highlights the increasing significance of rapid screening technologies as a primary trend propelling market expansion. With advancements in technologies such as Gas Chromatography-Mass Spectrometry (GC-MS), toxicology laboratories are witnessing a surge in demand for efficient screening methods, enhancing turnaround times and sensitivity.

Integration of Informatics and Data Solutions

Another pivotal trend identified in the report is the integration of informatics and data solutions within toxicology laboratories. Confidential test results are securely stored in mass spectral databases, emphasizing the importance of data integrity and confidentiality in the industry.

Key Segment Insights

  • Drug Class Dominance: Amphetamines emerge as the leading segment, capturing 17.9% of the market share and projected to grow at a robust CAGR of 11.0% during the forecast period.
  • Product Type Leadership: Reagent and kits claim the majority share of 61.6%, expected to grow at a steady CAGR of 9.7% over the forecast period.

Regulatory Frameworks Fueling Market Growth

The report underscores the role of robust regulatory frameworks in driving market growth across industries such as pharmaceuticals, cosmetics, food, and chemicals. Stricter regulations in the US and Canada mandate rigorous testing, creating a conducive environment for market expansion.

Challenges and Opportunities

While traditional toxicology laboratories face challenges from the introduction of point-of-care testing devices, increasing government spending on toxicity testing presents lucrative opportunities for market players. Collaborations between regulatory bodies and industry stakeholders further stimulate innovation and growth.

Competitive Analysis

Prominent organizations are spearheading the sector with innovative solutions and strategic alliances. Competitive intelligence and strategic decision-making remain crucial for companies navigating the dynamic landscape of the toxicology laboratories market.

Global North America Toxicology Laboratories Market:

  • Thermo Fisher Scientific, Inc.
  • Bio Rad Laboratories Inc.
  • Neogen Corporation
  • Danaher Corporation
  • Agilent
  • Redwood Toxicology Laboratory
  • Abbott (Alere, Inc.)

Global North America Toxicology Laboratories Market Is Segmented as Below:

Drug Class:

  • Alcohol
  • Amphetamines
  • Barbiturates
  • Benzodiazepines
  • Illicit Drugs
  • Opiates/Opioids
  • Tricyclic's Antidepressants
  • Z Drugs
  • Misc

Product Type:

  • Reagent Kits
    • ELISA
    • PCR
    • Enzyme Multiplied Immunoassay Technique (EMIT)
    • Radio Immuno-sorbent Assay (RIA)
  • Instruments
    • Immunochemistry Analyzers
    • PCR Machine
    • Gas Chromatography/Mass Spectrometry (GS/MS)
    • High Performance Liquid Chromatography (HPLC)

Sample:

  • Urine
  • Blood
  • Hair
  • Oral Fluid

End User:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Rehabilitation Centers

By Geographic Coverage:

  • North America
    • U.S.
    • Canada

Table of Contents

1. Executive Summary

  • 1.1. North America Toxicology Laboratories Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2022
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. Covid-19 Impact Analysis
    • 2.5.1. Overview
    • 2.5.2. Impact By Region
  • 2.6. Economic Overview
    • 2.6.1. World Economic Projections
  • 2.7. PESTLE Analysis

3. North America Toxicology Laboratories Market Outlook, 2018 - 2030

  • 3.1. North America Toxicology Laboratories Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2030
    • 3.1.1. Key Highlights
      • 3.1.1.1. Alcohol
      • 3.1.1.2. Amphetamines
      • 3.1.1.3. Barbiturates
      • 3.1.1.4. Benzodiazepines
      • 3.1.1.5. Illicit Drugs
      • 3.1.1.6. Opiates/Opioids
      • 3.1.1.7. Tricyclic's Antidepressants
      • 3.1.1.8. Z Drugs
      • 3.1.1.9. Others
  • 3.2. North America Toxicology Laboratories Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2030
    • 3.2.1. Key Highlights
      • 3.2.1.1. Reagent Kits
        • 3.2.1.1.1. ELISA
        • 3.2.1.1.2. PCR
        • 3.2.1.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
        • 3.2.1.1.4. Radio Immuno-sorbent Assay (RIA)
      • 3.2.1.2. Instruments
        • 3.2.1.2.1. Immunochemistry Analyzers
        • 3.2.1.2.2. PCR Machine
        • 3.2.1.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
        • 3.2.1.2.4. High Performance Liquid Chromatography (HPLC)
  • 3.3. North America Toxicology Laboratories Market Outlook, by Sample, Value (US$ Mn), 2018 - 2030
    • 3.3.1. Key Highlights
      • 3.3.1.1. Urine
      • 3.3.1.2. Blood
      • 3.3.1.3. Hair
      • 3.3.1.4. Oral Fluid
    • 3.3.2. Market Attractiveness Analysis
  • 3.4. North America Toxicology Laboratories Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
    • 3.4.1. Key Highlights
      • 3.4.1.1. U.S. Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 - 2030
      • 3.4.1.2. U.S. Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 - 2030
      • 3.4.1.3. U.S. Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 - 2030
      • 3.4.1.4. Canada Toxicology Laboratories Market by Drug Class, Value (US$ Mn), 2018 - 2030
      • 3.4.1.5. Canada Toxicology Laboratories Market, by Product Type, Value (US$ Mn), 2018 - 2030
      • 3.4.1.6. Canada Toxicology Laboratories Market, by Sample, Value (US$ Mn), 2018 - 2030
    • 3.4.2. Market Attractiveness Analysis

4. Competitive Landscape

  • 4.1. Company Market Share Analysis, 2022
  • 4.2. Market Concentration by Top Players
  • 4.3. Competitive Dashboard
  • 4.4. Company Profiles
    • 4.4.1. Thermo Fisher Scientific
      • 4.4.1.1. Company Overview
      • 4.4.1.2. Product Portfolio
      • 4.4.1.3. Financial Overview
      • 4.4.1.4. Business Strategies and Development
    • 4.4.2. Bio-Rad Laboratories, Inc.
      • 4.4.2.1. Company Overview
      • 4.4.2.2. Product Portfolio
      • 4.4.2.3. Financial Overview
      • 4.4.2.4. Business Strategies and Development
    • 4.4.3. NEOGEN Corporation
      • 4.4.3.1. Company Overview
      • 4.4.3.2. Product Portfolio
      • 4.4.3.3. Financial Overview
      • 4.4.3.4. Business Strategies and Development
    • 4.4.4. Redwood Toxicology Laboratory, Inc.
      • 4.4.4.1. Company Overview
      • 4.4.4.2. Product Portfolio
      • 4.4.4.3. Financial Overview
      • 4.4.4.4. Business Strategies and Development
    • 4.4.5. Vala Sciences, Inc.
      • 4.4.5.1. Company Overview
      • 4.4.5.2. Product Portfolio
      • 4.4.5.3. Financial Overview
      • 4.4.5.4. Business Strategies and Development
    • 4.4.6. Enzo Life Sciences, Inc.
      • 4.4.6.1. Company Overview
      • 4.4.6.2. Product Portfolio
      • 4.4.6.3. Financial Overview
      • 4.4.6.4. Business Strategies and Development
    • 4.4.7. Alere, Inc.
      • 4.4.7.1. Company Overview
      • 4.4.7.2. Product Portfolio
      • 4.4.7.3. Financial Overview
      • 4.4.7.4. Business Strategies and Development
    • 4.4.8. Agilent Technologies, Inc.
      • 4.4.8.1. Company Overview
      • 4.4.8.2. Product Portfolio
      • 4.4.8.3. Financial Overview
      • 4.4.8.4. Business Strategies and Development
    • 4.4.9. Immunalysis Corporation
      • 4.4.9.1. Company Overview
      • 4.4.9.2. Product Portfolio
      • 4.4.9.3. Financial Overview
      • 4.4.9.4. Business Strategies and Development
    • 4.4.10. Danaher Corporation
      • 4.4.10.1. Company Overview
      • 4.4.10.2. Product Portfolio
      • 4.4.10.3. Financial Overview
      • 4.4.10.4. Business Strategies and Development
    • 4.4.11. Principle Diagnostics Laboratory
      • 4.4.11.1. Company Overview
      • 4.4.11.2. Product Portfolio
      • 4.4.11.3. Financial Overview
      • 4.4.11.4. Business Strategies and Development
    • 4.4.12. Principle Laboratory
      • 4.4.12.1. Company Overview
      • 4.4.12.2. Product Portfolio
      • 4.4.12.3. Financial Overview
      • 4.4.12.4. Business Strategies and Development
    • 4.4.13. Principle Diagnostics Laboratory
      • 4.4.13.1. Company Overview
      • 4.4.13.2. Product Portfolio
      • 4.4.13.3. Financial Overview
      • 4.4.13.4. Business Strategies and Development
    • 4.4.14. Clinical Reference Laboratory, Inc.
      • 4.4.14.1. Company Overview
      • 4.4.14.2. Product Portfolio
      • 4.4.14.3. Financial Overview
      • 4.4.14.4. Business Strategies and Development
    • 4.4.15. Medical Toxicology Laboratory, LLC
      • 4.4.15.1. Company Overview
      • 4.4.15.2. Product Portfolio
      • 4.4.15.3. Financial Overview
      • 4.4.15.4. Business Strategies and Development
    • 4.4.16. NMS Labs
      • 4.4.16.1. Company Overview
      • 4.4.16.2. Product Portfolio
      • 4.4.16.3. Financial Overview
      • 4.4.16.4. Business Strategies and Development
    • 4.4.17. BATTS Laboratories
      • 4.4.17.1. Company Overview
      • 4.4.17.2. Product Portfolio
      • 4.4.17.3. Financial Overview
      • 4.4.17.4. Business Strategies and Development
    • 4.4.18. Total Toxicology
      • 4.4.18.1. Company Overview
      • 4.4.18.2. Product Portfolio
      • 4.4.18.3. Financial Overview
      • 4.4.18.4. Business Strategies and Development
    • 4.4.19. Life Brite Labs.
      • 4.4.19.1. Company Overview
      • 4.4.19.2. Product Portfolio
      • 4.4.19.3. Financial Overview
      • 4.4.19.4. Business Strategies and Development
    • 4.4.20. Product Safety Labs
      • 4.4.20.1. Company Overview
      • 4.4.20.2. Product Portfolio
      • 4.4.20.3. Financial Overview
      • 4.4.20.4. Business Strategies and Development
    • 4.4.21. Lexar Labs
      • 4.4.21.1. Company Overview
      • 4.4.21.2. Product Portfolio
      • 4.4.21.3. Financial Overview
      • 4.4.21.4. Business Strategies and Development

5. Appendix

  • 5.1. Research Methodology
  • 5.2. Report Assumptions
  • 5.3. Acronyms and Abbreviations